HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc. (HOOK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HOOK · as of Jun 9, 2026
Key Statistics
Explore HOOKIPA Pharma Inc. Data
hook stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 55.6%
The HOOK analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $3.00, representing +160.87% upside from the current price of $1.15.
Competitors & Peers
hook competitorsHOOK
CHMMF
DVHGF
HMTXF
IMUC
LIANYStock Performance
Full HistoryAbout HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc. operates as a clinical-stage biopharmaceutical firm dedicated to advancing immunotherapies for infectious diseases and various cancers. This endeavor is powered by its proprietary …
what is hookipa pharma inc. · hook stock overview · hookipa pharma inc. company profile · who is hookipa pharma inc. ceo · hook OTC · hookipa pharma inc. headquarters · hookipa pharma inc. business segments
About Stock Overview & Key Data
HOOKIPA Pharma Inc. (HOOK) is a Healthcare company in the Biotechnology industry, listed on OTC since Apr 18, 2019. As of the latest trading session, HOOK stock price is $1.15, with a market capitalization of $14.4M. The stock has returned -24.84% over the past 12 months and +28.78% year-to-date.
According to 9 Wall Street analysts, the consensus rating for HOOKIPA Pharma Inc. stock is Buy, with an average 12-month price target of $3.00. In fiscal year 2025, HOOKIPA Pharma Inc. reported revenue of $9.7M and net income of -$13.8M. For detailed data — including HOOKIPA Pharma Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, HOOKIPA Pharma Inc. (HOOK) stock price is $1.15. The stock is traded on OTC under the ticker symbol HOOK. The 52-week range is $0.81 – $1.65.